Shenzhen Bioeasy Biotechnology Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 165.1 million compared to CNY 572.09 million a year ago. Revenue was CNY 165.1 million compared to CNY 572.09 million a year ago.

Net loss was CNY 99.16 million compared to net income of CNY 148.36 million a year ago. Basic loss per share from continuing operations was CNY 0.2474 compared to basic earnings per share from continuing operations of CNY 0.3701 a year ago. Diluted loss per share from continuing operations was CNY 0.2474 compared to diluted earnings per share from continuing operations of CNY 0.3701 a year ago.